RYTM - Rhythm Pharmaceuticals, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts8488
Avg. Estimate-0.89-0.9-3.94-3.41
Low Estimate-1.06-0.99-4.19-4.5
High Estimate-0.71-0.86-3.74-2.82
Year Ago EPS-0.74-0.84-2.39-3.94
Revenue EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts7488
Avg. EstimateN/AN/A30k19.96M
Low EstimateN/AN/AN/A1.63M
High EstimateN/AN/A250k80.7M
Year Ago SalesN/AN/AN/A30k
Sales Growth (year/est)N/AN/AN/A66,433.29%
Earnings History12/30/20183/30/20196/29/20199/29/2019
EPS Est.-0.57-0.76-0.88-1.07
EPS Actual-0.74-0.84-1.24-1.04
Difference-0.17-0.08-0.360.03
Surprise %-29.80%-10.50%-40.90%2.80%
EPS TrendCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Current Estimate-0.89-0.9-3.94-3.41
7 Days Ago-0.89-0.9-3.94-3.41
30 Days Ago-0.88-0.91-3.93-3.4
60 Days Ago-0.89-0.91-3.93-3.4
90 Days Ago-1.08-1.07-4.18-3.89
EPS RevisionsCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesRYTMIndustrySectorS&P 500
Current Qtr.-20.30%N/AN/A0.01
Next Qtr.-7.10%N/AN/A0.06
Current Year-64.90%N/AN/A-0.03
Next Year13.50%N/AN/A0.14
Next 5 Years (per annum)16.10%N/AN/A0.07
Past 5 Years (per annum)N/AN/AN/AN/A